Diamondis Papadopoulos, MD
MOHS-Micrographic Surgery · Atlanta, GANPI 1023015690
Payments from drug & device makers
What this record shows
This record is dominated by consulting fees: $8,460 of the $9,448 with a category attached, or 89.5%. Regeneron Healthcare Solutions, Inc. accounts for 85.7% of it on its own, with 12 other manufacturers making up the rest. Reporting peaked in 2020 at $7,809 and has fallen 99.4% since, to $47 in 2025.
Across 26 payments — averaging $363.39 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Regeneron Healthcare Solutions, Inc.$8K
- Regeneron$705
- AbbVie$171
- Mentor Worldwide LLC$129
- LEO Pharma Inc.$117
- Organogenesis Inc.$56
- plus $176 from 7 others
Across 47 payments — averaging $6666.50 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Regeneron$214K
- AbbVie$99K
What the payments were for
- Consulting fees$8,46090%
- Travel & lodging$1792%
- Food & beverage$8099%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Regeneron Healthcare Solutions, Inc. | 6 | $8,094 |
| Regeneron | 1 | $705 |
| AbbVie(2 entities) | 6 | $171 |
| Mentor Worldwide LLC | 1 | $129 |
| LEO Pharma Inc. | 3 | $117 |
| Organogenesis Inc. | 2 | $56 |
| Kerecis Limited | 1 | $48 |
| Novartis | 1 | $31 |
| Merz North America, Inc. | 1 | $25 |
| Pfizer | 1 | $22 |
| Sanofi | 1 | $20 |
| E.r. Squibb & Sons, L.L.C. | 1 | $15 |
| Genentech USA, Inc. | 1 | $15 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- LIBTAYO$8,460
- KEVZARA$145
- MENTOR MemoryGel Resterilizable Gel Sizer$129
How this compares
$9,448 in reported general payments places this provider in the 80th percentile of 40 mohs-micrographic surgery providers in Georgia.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Mupirocin | 356 | $2,264 |
| Doxycycline Hyclate | 185 | $1,354 |
| Fluocinonide | 17 | $724 |
| Clobetasol Propionate | 11 | $640 |
| ValacyclovirValacyclovir Hcl | 11 | $567 |
| Minoxidil | 19 | $220 |
| Triamcinolone Acetonide | 14 | $185 |
| Ketoconazole | 16 | $146 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 19 | $116 |
Paid to pharmacies, not to this prescriber.
Other mohs-micrographic surgery in Atlanta
- David OlanskyAtlanta$13K
- Melissa BabcockAtlanta$3K
- Humza IlyasAtlanta$3K
- Julia NeckmanAtlanta$3K
- Valerie TruongAtlanta$2K
- Mary Alice MinaAtlanta$533
- Amy KimAtlanta$430
- Mark BaucomAtlanta$146
- Wallace NozileStockbridge$213K
- Brandon BurrowayDuluth$30K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.